Curriculum Vitae
Todd A. Kellogg, M.D., Department of Surgery in the Medical School at the University of Minnesota

Work Address
Appointments
Education
Training
Research Experience
Teaching Experience
Grants and Awards
Professional Societies
Certification and Licensure
Languages
Presentations
Book Chapters
Publications

WORK ADDRESS:

MMC 195, Department of Surgery
University of Minnesota
416 Delaware Street S.E.
Minneapolis, MN 55455

Contact:

Telephone: (651) 493-2823
Fax: (612) 625-3206
Email: kell0018@umn.edu

Top of page

APPOINTMENTS:

7/2004 to present
Assistant Professor of Surgery
Center for Minimally Invasive Surgery
Department of Surgery
University of Minnesota

7/2003 to 6/2004
Instructor
Department of Surgery
University of Minnesota

7/2002 to 6/2003
Acting Instructor
Center for Videoendoscopic Surgery
Department of Surgery
University of Washington

Top of page

EDUCATION:

1996-2000 Postdoctoral fellow, University of Minnesota Graduate School. Molecular Determinants of Lipopolysaccharide-Protein Antagonist Interactions.

1989-1993 University of Minnesota Medical School
Degree: Doctor of Medicine

1982-1984 University of Washington
Degree: Bachelor of Science
Major: Cell and Molecular Biology

1980-1982 Oregon State University
Major: Marine Biology

Top of page

TRAINING:

7/03-present Instructor / Bariatric Fellow
Center for Minimally Invasive Surgery
University of Minnesota
Sayeed Ikramuddin, MD and Henry Buchwald, MD, Program Directors

7/02-6/03 Fellow, Minimally Invasive Surgery
Center for Videoendoscopic Surgery
University of Washington
Carlos A. Pellegrini, MD, Chair and Program Director

6/01-7/02 Administrative Chief Resident, General Surgery University of Minnesota, Department of Surgery
David L. Dunn, MD, PhD, Chair and Program Director

7/94-6/02 Residency, General Surgery
University of Minnesota, Department of Surgery
David L. Dunn, MD, PhD, Chair and Program Director

7/96-6/00 Laboratory Fellow
University of Minnesota, Department of Surgery
David L. Dunn, MD, PhD, Mentor

7/96-12/99 Surgical Infectious Disease Fellow
University of Minnesota, Department of Surgery

1/98-7/98 Surgical Endoscopy Fellow
University of Minnesota, Department of Surgery
Robert Goodale, MD, Director

6/93-7/94 Internship, General Surgery
University of Minnesota, Department of Surgery
John Najarian, MD, Chair

Top of page

RESEARCH EXPERIENCE:

1. Randomized prospective trial of paraesophageal hernia repair with small intestinal submucosa under Carlos A. Pellegrini, MD. Swallowing Center, Department of Surgery, University of Washington. 7/1/02 to 6/30/03.

2. Endotoxin research investigating the molecular mechanisms of lipopolysaccharide-protein antagonist interactions under David L. Dunn, MD, PhD. Department of Surgery, University of Minnesota. 7/1996 to 6/2000.

3. Basic science research as an undergraduate student under Steven C. Woods, PhD investigating direct neural control of adipose tissue lipoprotein lipase, University of Washington Department of Behavioral Psychology, 1982-1984.

Top of page

TEACHING EXPERIENCE:

1. Instructor, Laparoscopic Ventral Hernia Repair Course for practicing surgeons, University of Washington, Center for Videoendoscopic Surgery, November 2002, May 2003.

2. Instructor, Laparoscopy Teaching Laboratory for surgery residents, University of Washington, Center for Videoendoscopic Surgery, July 2002-June 2003.

3. Instructor, Surgery Laboratory for medical students, University of Minnesota, 1996-2000.

4. English teacher, Guangdong College of Medicine and Pharmacy 1987-1988, Guangzhou, Guangdong, China.

Top of page

GRANTS AND AWARDS:

1. National Research Service Award (NRSA), National Institutes of Health. 1997-2000 (2.5 years). GM-19030.

2. Watson Award for outstanding research accomplishment by a physician in graduate clinical training at the University of Minnesota, May 1998.

3. Surgical Infection Society Award for best poster presentation. Endotoxin antagonists exhibit differential epitope binding. Presented at the Surgical Infection Society annual meeting, April 27-29, 2000.

4. Minnesota Medical Foundation Student Research Grant, 1991.

5. High-scholarship, University of Washington 1982-1984.

Top of page

PROFESSIONAL SOCIETIES:

1. The society of American Gastrointestinal Endoscopic Memberships Surgeons (SAGES), 2002-present.

2. American College of Surgeons (ACS) Candidate Group, 1996-present.

3. American Medical Association (AMA), 1999-present.

Top of page

CERTIFICATION AND LICENSURE:

1. Minnesota Medical License #39652

2. Washington State Medical License #025209 MD00041283

3. Advanced Trauma Life Support 12/93

4. Advanced Cardiac Life Support 5/94

5. Basic Life Support 6/93

Top of page

LANGUAGES:

1. French (fluent)

2. Chinese

Top of page

PRESENTATIONS:

1. Kellogg T, Raziel A, Schlosser C, Buchwald H, Ikramuddin S. Age greater than 60 is not a contra-indication to Roux-en-Y gastric bypass. Presented at the 9th World Congress of the International Federation for the Surgery of Obesity, September 8-12, 2004, Tokyo.

2. Kellogg T, Oelschlager B, Mulligan M, Pellegrini, C. Right-sided paraesophageal hernias: A different entity requiring a different clinical approach? Presented at the Seattle Surgical Society annual scientific meeting, January 17-18, 2003, Seattle.

3. Kellogg T, Lazaron V, Wasiluk K, Dunn D. Endotoxin antagonists exhibit differential epitope binding. Presented at the Surgical Infection Society annual meeting, April 27-29, 2000, Providence, RI.

4. Kellogg T, Johnston J, Weiss C, Wasiluk K, Dunn D. Use of genetic engineering to create a potent single chain Fv endotoxin antagonist. Presented at the Surgical Forum, 85th Congress of the American College of Surgeons, October 10-15, 1999, San Francisco.

5. Kellogg T, Weiss C, Johnston J, Dunn D. Characterization of a monoclonal antibody that mimics the toxic lipid A region of lipopolysaccharide. Presented at the Surgical Infection Society annual meeting, April 30, 1998, New York.

6. Kellogg T, Johnston J, Weiss C, Wasiluk K, Dunn D. Anti-endotoxin (LPS) agents demonstrate molecular homology within their LPS binding domains. Presented at the Association for Academic Surgery 32nd annual meeting, November 19-22, 1998, Seattle.

7. Kellogg T, Goodale R. Pitfalls in laparoscopic cholecystectomy. Presented at the 60th Annual Surgery Course: Advances in Gastrointestinal and GI Laparoscopic Surgery. June 10-13, 1998, Minneapolis.

Top of page

BOOK CHAPTERS:

1. Kellogg TA, Ikramuddin, S. Laparoscopic conversion of vertical banded gastroplasty to Roux-en-Y gastric bypass. In: Bariatric Surgery: Principles and Practice. 1st ed. (in press).

2. Kellogg TA, Ikramuddin S. Laparoscopic gastric banding. In: The SAGES Manual: Fundamentals of laparoscopy and GI surgery. 2nd Ed. Scott-Conner CEH. (ed.), Springer, New York (in press).

3. Kellogg TA, Oelschlager BK, Pellegrini CA. Complications in laparoscopic gastroesophageal reflux surgery. In: Management of Laparoscopic Surgical Complications, 1st ed. LeBlanc K. (ed.), Marcel Dekker, New York (in press).

4. Kellogg TA, Oelschlager BK, Pellegrini CA. Surgery and the GI Tract: surgery of the esophagus. In: GI/Liver Secrets, 3rd ed. McNally PR (ed.) Hanley & Belfus, Philadelphia (in press).

Top of page

PUBLICATIONS:

1. Kellogg TA, Horvath KD. Minimal-access approaches to complications of acute pancreatitis and benign neoplasms of the pancreas. Surg Endosc. Sep 10, 2003 [Epub ahead of print].

2. Kellogg TA, Oelschlager BK, Pellegrini CA. Laparoscopic antireflux surgery. Visible Human Journal of Endoscopy (online) 2(3): http://www.vhjoe.com/Volume2Issue3/2-3-3.htm, 2003.

3. Kellogg TA, Oelschlager BK, Pellegrini CA. Laparoscopic bariatric surgery. Visible Human Journal of Endoscopy (online) in press, 2003.

4. Kellogg T, Lazaron V, Wasiluk K, Dunn D. Binding specificity of Polymyxin B, BPI, LALF, and anti-deep core / lipid A monoclonal antibody to lipopolysaccharide partial structures. Shock 15(2): 124-129, 2001.

5. Kellogg T, Johnston J, Weiss C, Wasiluk K, Dunn D. Anti-endotoxin agents share molecular homology within their lipopolysaccharide binding domains. J Surg Res 85, 136-141, 1999.

6. Kellogg T, Johnston J, Weiss C, Wasiluk K, Dunn D. Use of genetic engineering to create a potent single chain Fv endotoxin antagonist. ACS Surgical Forum Vol. L, 226-228, 1999.

Top of Page


©2002 Regents of the University of Minnesota. All rights reserved.

The University of Minnesota is an equal opportunity educator and employer.

Last modified on Wednesday Oct 27, 2004

This page is located at http://www.med.umn.edu//surgery/Faculty/kellogg_todd_a/kellogg_cv.html